FDA Panel Mulls Ban on Kids' Cold Medicines


This is the 21st century of media technology, and Paul Passanante is maximizing his influence among 60 million viewers on AOL Television, iTunes, CBS and The InsiderExclusive TV Show with Steve Murphy.
Paul was also just selected for and interviewed on "America's Premier Laywers" (www.americaspremierlawyers.org) and The LawBusiness Insider www.lbishow.com, which is featured in Fortune Magazine and broadcast worldwide on American Airlines and Northwest Airlines. He is currently reviewing - and has the experience to fully analyze - this story about how a panel of experts at the U.S. Food and Drug Administration will consider banning the sale of over-the-counter cough and cold medicines for young children.Such a ban already has the support of safety experts at the FDA, who published a 365-page review on the issue in late September. Any recommendation from the advisory panel would apply to decongestant use in children under 2, and antihistamines in those younger than 6. While the FDA does not have to follow a panel's recommendation, it usually does. According to the FDA safety review, decongestants and antihistamines have been linked with 123 pediatric deaths since 1969. Many outside experts are also in favor of restricting children's access to cold remedies.You can reach Mr. Passanante at 314-241-2929, or email ppassanante@spstl-law.com








































